News

MNM's platform ARETE works!

Date
July 26, 2022
No items found.

MNM's platform ARETE - a proprietary AI technology designed for cancer genomics has been successfully externally validated by one of our Partners.

Using WGS and NGS as input data, ARETEAI created a predictive algorithm with outstanding accuracy! Further improvement will be achieved by feeding the AI with more data. The most important part is that the best model is from our proprietary AI architecture, which we’ve been building for the past two years.

You may also like

“Random similarity forests” has been accepted at ECML PKDD 2022

We are very happy to announce that our abstract and related publication titled “Random similarity forests” has been accepted at this year’s European Conference on Machine Learning and Principles and Practice of Knowledge Discovery in Databases- #ECMLPKDD2022!

MNM Bioscience announced that it had filed a provisional patent application

MNM Bioscience announced that it had filed a provisional patent application

Publication in Molecular Diagnosis & Therapy has been just released

MNM Biosciences, in co-operation with leading Polish cancer centers, has recently published a breakthrough publication concerning breast cancer diagnostics.

Krzysztof Bokiej is a speaker at Data Science Summit ML Edition

Krzysztof Bokiej - Head of Platform and Pipelines at MNM - is a speaker at the most important Machine Learning conference in Poland.